Smith & Nephew SNATS (NYSE:SNN) Sees Unusually-High Trading Volume - Time to Buy?

Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Get Free Report) saw an uptick in trading volume on Wednesday . 1,805,283 shares traded hands during trading, an increase of 122% from the previous session's volume of 812,288 shares.The stock last traded at $30.51 and had previously closed at $29.77.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on SNN. Hsbc Global Res cut shares of Smith & Nephew SNATS from a "strong-buy" rating to a "hold" rating in a research report on Friday, April 25th. HSBC cut shares of Smith & Nephew SNATS from a "buy" rating to a "hold" rating in a research report on Friday, April 25th. Finally, Canaccord Genuity Group upped their target price on shares of Smith & Nephew SNATS from $27.00 to $28.00 and gave the stock a "hold" rating in a research note on Thursday, May 1st. Six research analysts have rated the stock with a hold rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $28.00.

Smith & Nephew SNATS Stock Performance

The stock has a market capitalization of $13.27 billion, a price-to-earnings ratio of 14.02, a price-to-earnings-growth ratio of 0.93 and a beta of 0.69. The company has a current ratio of 2.89, a quick ratio of 1.33 and a debt-to-equity ratio of 0.62. The stock's 50 day moving average is $29.33 and its two-hundred day moving average is $27.46.

Institutional Investors Weigh In On Smith & Nephew SNATS

Several institutional investors and hedge funds have recently added to or reduced their stakes in SNN. Hexagon Capital Partners LLC raised its holdings in shares of Smith & Nephew SNATS by 63.3% in the 1st quarter. Hexagon Capital Partners LLC now owns 1,047 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 406 shares during the period. Richards Merrill & Peterson Inc. raised its holdings in shares of Smith & Nephew SNATS by 500.0% in the 1st quarter. Richards Merrill & Peterson Inc. now owns 1,200 shares of the medical equipment provider's stock valued at $34,000 after purchasing an additional 1,000 shares during the period. National Bank of Canada FI raised its holdings in shares of Smith & Nephew SNATS by 36.5% in the 4th quarter. National Bank of Canada FI now owns 1,667 shares of the medical equipment provider's stock valued at $41,000 after purchasing an additional 446 shares during the period. Bessemer Group Inc. raised its holdings in shares of Smith & Nephew SNATS by 3,471.4% in the 1st quarter. Bessemer Group Inc. now owns 1,750 shares of the medical equipment provider's stock valued at $49,000 after purchasing an additional 1,701 shares during the period. Finally, Banque Transatlantique SA bought a new stake in shares of Smith & Nephew SNATS in the 1st quarter valued at about $52,000. 25.64% of the stock is owned by institutional investors.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.